The bladder cancer drug Bacillus Calmette-Guerin is in shortage, forcing thousands of patients to receive rationed treatments instead of a full regimen, CNN reported Feb. 15.
Read the full post on Becker's Hospital Review - Healthcare News
Thousands can't access a vital cancer drug treatment
